Boehringer Ingelheim

As part of the German pharmaceutical company Boehringer Ingelheim, the Boehringer Ingelheim Regional Center Vienna (RCV) has business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia, as well as for Israel and Switzerland. Vienna is also the global center of Boehringer Ingelheim's cancer research. Another focus lies in the development and production of biopharmaceutical drugs, which are also manufactured for third-party suppliers.

Boehringer Ingelheim aims to improve human and animal health by developing breakthrough therapies. In this context, the application of sustainable methods and processes in research, development and production is of particular importance.